NCT02285959 2022-08-10
Super-Selective Intraarterial Intracranial Infusion of Bevacizumab (Avastin) for Glioblastoma Multiforme
Global Neurosciences Institute
Phase 1 Unknown
Global Neurosciences Institute
Shanghai Zhongshan Hospital
Massachusetts General Hospital
Genor Biopharma Co., Ltd.
Assistance Publique Hopitaux De Marseille
National Taiwan University Hospital
Premiere Oncology of Arizona